Tumor cell biomolecules

The term Tumor cell biomolecules refers to a broad and heterogeneous collection of molecules found within or on the surface of neoplastic cells, including proteins, nucleic acids, lipids, and carbohydrates. Because this term encompasses virtually all molecular components of a cancer cell, it does not represent a single, well-defined therapeutic target suitable for drug development. In modern oncology and pharmacology, research focuses on specific subsets of these biomolecules, such as oncogenic drivers, cell surface receptors, or metabolic enzymes, to achieve precision in treatment. Targeting tumor cell biomolecules as a collective entity is not a standard clinical approach; instead, therapies are designed to hit specific, validated targets like EGFR, HER2, or PD-L1. Consequently, this term is considered too broad and non-specific for use as a canonical target name in drug discovery or clinical databases.

Other names

Cancer cell moleculesTumor-associated molecules

Not applicable as this is a broad category of molecules rather than a specific therapeutic target.